Navigation Links
Galil Medical Announces Establishment of Global Headquarters in Minneapolis, MN
Date:9/30/2009

MINNEAPOLIS, Sept. 30 /PRNewswire/ -- Galil Medical, a global leader in minimally invasive cryotherapy treatments for cancers and other disorders, announced today that it is establishing its new Global Headquarters in Minneapolis, MN. The company is expected to open this new facility in Arden Hills during the fourth quarter of 2009. Along with its corporate staff and US operations' functions, the company will also locate its global marketing, clinical/regulatory and its systems development and assembly functions in this new facility. Galil Medical will maintain needle manufacturing and R&D operations in its facility in Yokneam, Israel, as well as its European headquarters in London.

Martin J. Emerson, President and CEO, of Galil Medical comments: "We are excited about locating our Global Headquarters in Minneapolis. We feel the strong medical device presence in the greater Minneapolis and St. Paul area will give us access to a wide range of important resources and talent."

James E. Thomas, General Partner of Thomas, McNerney & Partners and member of Galil's Board of Directors, commented: "The decision to locate Galil's Global Headquarters in the Minneapolis area is part of our five year strategic plan recently approved by the Board of Directors. This plan includes the necessary funding for clinical data that will further document the value of cryotherapy for the focal treatment of prostate cancer and the treatment of renal cancer. Importantly, the plan also includes funding for advancing the state of the art cryotherapy technology."

Emerson concluded, "Galil Medical is now the only company solely devoted to the growth and development of cryotherapy. We have the experience, resources and commitment to pursue these goals for years to come."

About Galil Medical Galil Medical is a global medical device company that develops, manufactures and markets innovative products utilizing a proprietary cryoablation platform that incorporates powerful freezing technology and revolutionary 17-gauge cryoablation needle design. The company has offices in Yokneam, Israel; Plymouth Meeting, Pennsylvania; and London. Shareholders include Thomas, McNerney & Partners, The Vertical Group, Investor Growth Capital, Elron Electronic Industries Ltd. (Nasdaq: ELRN) and RDC Rafael Development Corporation, Ltd.

SOURCE Galil Medical


'/>"/>
SOURCE Galil Medical
Copyright©2009 PR Newswire.
All rights reserved

Related medicine technology :

1. Leading Medical Device Provider Chooses TrackWise(R) Software to Optimize Customer Complaint Handling
2. ReBuilder Medical Technologies, Inc. Reports LOI With National DME Distributor
3. New Micro-Bland Embolization Technique with Embozene(TM) Microspheres to Be Presented at the International Medical Conference in Lisbon, Portugal
4. American University of Beirut Medical Team Successfully Performs First Artificial Heart Implant in Lebanon
5. ATS Medical Announces FDA Approval for a Landmark Clinical Investigation of the ATS 3f Aortic Bioprosthesis
6. Mennen Medical Receives Frost & Sullivan 2009 European Patient Monitoring Technology Leadership Award
7. Medical World Recognises New Therapy for Reflux Babies
8. Amarex Clinical Research Selects OmniComm Systems to Provide eClinical Solutions for Phase III Medical Device Study and Joins OmniComms CRO Preferred Program
9. ProUroCare Medical Completes Clinical Trial at Second Study Site Using Digital Prostate Imaging Technology
10. CTMM Becomes One of the Worlds Largest Public-Private Partnerships in Translational Medical Research
11. Medigus and Tower Semiconductor Announce Worlds Smallest Medical Video Camera Based on Advanced CMOS Image Sensor
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/14/2017)... 2017  ivWatch LLC, a medical device company focused ... therapy, is pleased to announce it was the Bronze ... Supplies and Equipment at the 2017 Medical Design Excellence ... industry. The award was presented by Medical Device and ... in New York during MD&M ...
(Date:6/11/2017)... 2017  Eli Lilly and Company (NYSE: LLY ... studies of galcanezumab, an investigational treatment for the prevention ... several key secondary endpoints for galcanezumab compared to placebo ... (EVOLVE-1, EVOLVE-2 and REGAIN) will be presented today at ... Boston . "The ...
(Date:6/8/2017)... ANGELES , June 8, 2017   Responding to ... drug oversight and the death of singer Chris Cornell ... on Human Rights International offers a free online ... better educate consumers and families about psychotropic drug risks. ... Ledger , who died from an accidental overdose, has called ...
Breaking Medicine Technology:
(Date:6/23/2017)... (PRWEB) , ... June 23, 2017 , ... ... plastic surgeon practicing in Newburgh, New York, has recently begun offering three new ... to offering the best cutting-edge procedures and reducing downtime, Dr. Rubinstein is excited ...
(Date:6/23/2017)... ... ... Goodcents Deli Fresh Subs today announced the opening of a new restaurant in ... Kan. 66604 (near 21st and Gage). It is owned and operated by long-time Goodcents ... the Topeka and Bonner Springs, Kan. area. , “Goodcents has such a loyal ...
(Date:6/23/2017)... Georgia (PRWEB) , ... June 23, 2017 , ... ... Negative Breast Cancer Conference from Sept. 18 to 20. , The two-day conference ... (TNBC) subtype with the goal of improving patients’ lives and eliminating racial breast ...
(Date:6/23/2017)... ... June 23, 2017 , ... PureLife Dental is pleased to ... supplier for CDA members. As part of the amalgam separator endorsement, all CDA members ... more than $400 off the retail value. This partnership between PureLife and CDA is ...
(Date:6/23/2017)... CA (PRWEB) , ... June 23, 2017 , ... Ulster ... 26th June, 2017 from 9 am to 3 pm to present to graduate students ... program is an original curriculum project led by The Health Improvement Service of ...
Breaking Medicine News(10 mins):